PB, G., GV, B., RB, D., Jr, H. D., L, M., & CJ, P. (1999). Therapeutic benefit. Aspirin revisited in light of the introduction of clopidogrel. Stroke, 30(8), 1716. https://doi.org/10.1161/01.str.30.8.1716
Chicago Style (17th ed.) CitationPB, Gorelick, Born GV, D'Agostino RB, Hanley DF Jr, Moye L, and Pepine CJ. "Therapeutic Benefit. Aspirin Revisited in Light of the Introduction of Clopidogrel." Stroke 30, no. 8 (1999): 1716. https://doi.org/10.1161/01.str.30.8.1716.
MLA (9th ed.) CitationPB, Gorelick, et al. "Therapeutic Benefit. Aspirin Revisited in Light of the Introduction of Clopidogrel." Stroke, vol. 30, no. 8, 1999, p. 1716, https://doi.org/10.1161/01.str.30.8.1716.
Warning: These citations may not always be 100% accurate.